Daclizumab Biosimilar - Research Grade, Low Endotoxin

Daclizumab Biosimilar - Research Grade, Low Endotoxin

Catalog Number:
A001437404ICH
Mfr. No.:
ICH5021
Price:
$560
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Specificity: Detects human CD25. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Daclizumab.
          Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
          Isotype Control: Bulk Human IgG1 Isotype Control (IB1) [ICH2254]
          Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method

          Please contact us at for specific academic pricing.

          Background

          RUO daclizumab biosimilar is a therapeutic humanized monoclonal antibody which was used for the treatment of adults with relapsing forms of multiple sclerosis. Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T-cells.

      • Properties
        • Isotype
          IgG1
          Reactivity
          human
          Purification
          >95% by SDS-PAGE
          Formulation
          Sterile, preservative-free, solution in PBS. BSA and Azide free.
          Storage
          This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
          Molecular Weight
          5mg/ml

          * Products are for research use only. Not for use in diagnostic or therapeutic procedures.

      • Applications
        • Application
          Functional Assays

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.